Vista Pharmaceuticals Ltd Share Price

AGM Date: 25 Sep 2021

In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015 we herewith submit the 30th Annual Report for the Financial Year 2020-2021 along with Notice of the Annual General Meeting to be held on Saturday 25th day of September 2021 at 3.00 P.M through Video Conferencing (VC) /Other Audio Visual Means (OAVM) and the venue of meeting shall be deemed to be the registered office of the Company i.e. Plot Nos. 10 to 14 and 16 to 20 TSIIC Industrial Estate Gopalaipalli Village Narketpally Mandal Nalgonda District- 508254 Telangana. The Notice of AGM along with Annual report have been dispatched to the shareholders of the Company in compliance with the Circular No. 14/2020 dated April 08 2020 Circular No. 17/2020 dated April 13 2020 issued by the Ministry of Corporate Affairs followed by the Circular No. 20/2020 dated May 05 2020 and Circular No. 02/2021 dated January 13th 2021. Outcome/Proceedings - 30th Annual General Meeting of the Company held on Saturday 25th September 2021 at 03.00 P.M through video Conferencing (VC) / Other Audio Visual Means (OAVM). (As Per BSE Announcement Dated on 9/25/2021 4:17:24 AM) Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that the members of the Company have approved all the resolutions bearing item no. 1 & 2 contained in the Notice of 29th Annual General Meeting of the Company with requisite majority. The Company had appointed Mr. NVSS Suryanarayana Rao Company Secretary in practice as the Scrutinizer for remote e-voting and venue e-voting at the AGM. The Scrutinizer has submitted his report on 27th September 2021. In this connection we hereby enclose the consolidated results of the remote e-voting and venue e-voting at the Video Conferencing (VC) / Other Audio Visual Means (OAVM) meeting in the format prescribed together with the Scrutinizers Report. On the basis of the report received from the Scrutinizer the Company has declared that the Resolutions set out in the notice of 29th AGM were passed with requisite majority in favour of the Resolutions. Vista Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 9/27/2021 2:18:29 AM)

AGM Date: 29 Sep 2022

In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015, we herewith submit the 31st Annual Report for the Financial Year 2021-2022 along with Notice of the Annual General Meeting to be held on Thursday, 29th day of September, 2022 at 3.30 P.M through Video Conferencing ('VC') /Other Audio-Visual Means ('OAVM'). The Notice of AGM along with Annual report have been dispatched to the shareholders of the Company in compliance with the Circular No. 14/2020 dated April 08, 2020, Circular No. 17/2020 dated April 13, 2020 issued by the Ministry of Corporate Affairs followed by the Circular No. 20/2020 dated May 05, 2020 and Circular No. 02/2021 dated January 13th, 2021. This is to inform the exchange that pursuant to Section 96 of the Companies Act, 2013, read with Regulation 30 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015, pursuant to the Circular issued by the Ministry of Corporate Affairs and SEBI the 31st Annual General Meeting of the Company will be held on Thursday, 29th day of September, 2022 at 03.30 PM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). We further wish to inform you that the Company is providing e-voting facility to the shareholders to vote on the resolutions proposed to be passed at the 31st Annual General Meeting to be held on Thursday, 29th day of September, 2022 at 03.30 PM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). The e-voting will commence at 09.00 AM on Monday, 26th day of September, 2022 and ends at 05.00 PM on Wednesday, 28th day of September, 2022. In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015, we herewith submit the 31st Annual Report for the Financial Year 2021-2022 along with Notice of the Annual General Meeting to be held on Thursday, 29th day of September, 2022 at 3.30 P.M through Video Conferencing ('VC') /Other Audio-Visual Means ('OAVM'). The Notice of AGM along with Annual report have been dispatched to the shareholders of the Company in compliance with the Circular No. 14/2020 dated April 08, 2020, Circular No. 17/2020 dated April 13, 2020 issued by the Ministry of Corporate Affairs followed by the Circular No. 20/2020 dated May 05, 2020 and Circular No. 02/2021 dated January 13th, 2021. (As per BSE Announcement Dated on 7/9/2022) Subject: Summary of Outcome/Proceedings - 31st Annual General Meeting of the Company held on Thursday, 29th September, 2022 at 03.30 P.M. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). With reference to the above subject citied, the 31st Annual General Meeting (AGM) of the Members of Vista Pharmaceuticals Limited ('the Company') was held on Thursday, 29th September, 2022 at 03.30 P.M (IST) through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that the members of the Company have approved all the resolutions bearing item no. 1 & 2 contained in the Notice of 31st Annual General Meeting of the Company with requisite majority. The Company had appointed Mr. NVSS Suryanarayana Rao, Company Secretary in practice as the Scrutinizer for remote e-voting and venue e-voting at the AGM. The Scrutinizer has submitted his report on 29th September, 2022. In this connection we hereby enclose the consolidated results of the remote e-voting and venue e-voting at the Video Conferencing (VC) / Other Audio Visual Means (OAVM) meeting in the format prescribed together with the Scrutinizer's Report. On the basis of the report received from the Scrutinizer, the Company has declared that the Resolutions set out in the notice of 31st AGM were passed with requisite majority in favour of the Resolutions. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 30 Sep 2023

Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This corrigendum is issued in connection with the Annual General Meeting notice dated 06.09.2023 and should be read in conjunction with the original notice 06.09.2023 (As Per BSE Announcement dated on 27.09.2023) The outcome of 32nd Annual General Meeting of the Company which was held on the 30th Day of September 2023 at 11:00 AM through mode. (As per BSE Announcement Dated on 30/09/2023) Scrutinizer report along with the voting results for the 29th Annual General Meeting of the Company held on 30th September 2023 through OVAM (As Per BSE Announcement Dated on 03/10/2023)

AGM Date: 30 Sep 2024

Notice is hereby given that the 33rd Annual General Meeting of members of M/s. Vista Pharmaceuticals Ltd will be held on Monday, the 30th day of September 2024 at 10.30 A.M. (IST) through Video Conferencing ('VC') / Other Audio-Visual Means (''OAVM') to transact the following businesses: AGM Outcome (As Per Bse Announcement Dated on 30.09.2024)

AGM Date: 30 Sep 2025

To convene the 34th Annual General Meeting (AGM') of the Members of the Company on Tuesday, the 30th day of September, 2025, at 11:00 A.M., to be conducted through Video Conferencing ('VC') / Other Audio-Visual Means (OAVM') in conformity with the MCA General Circulars and applicable statutory provisions. The venue of the AGM shall, for all legal purposes, be deemed to be the registered office of the Company. Outcome of AGM of Vista Pharmaceutical Limited held on 30.09.2025 (As Per BSE Announcement Dated on: 30/09/2025)

EGM Date: 14 Oct 2022

This is to inform the exchange that pursuant to Section 100 of the Companies Act, 2013, read with Regulation 30 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015, pursuant to the Circular issued by the Ministry of Corporate Affairs and SEBI, the Extra Ordinary General Meeting of the Company will be held on Friday, 14th day of October, 2022 at 03.30 PM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). We further wish to inform you that the Company is providing e-voting facility to the shareholders to vote on the resolutions proposed to be passed at the Extra Ordinary General Meeting to be held on Friday, 14th day of October, 2022 at 03.30 PM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). With reference to the subject cited, please find enclosed a corrigendum to the notice convening 1st of 2022-23) Extra ordinary General Meeting (EGM) of the Company to be held on Friday, 14th October, 2022 at 03.30 PM through Video Conferencing and Other Audio-Visual Means (VC & OAVM). Kindly take the above information on records. (As Per BSE Announcement Dated on 13.10.2022) With reference to the above subject citied, the (1st of 2022-23) Extra Ordinary General Meeting (EGM) of the Members of Vista Pharmaceuticals Limited ('the Company') was held on Friday, 14th October, 2022 at 03.30 P.M. (IST) through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). (As Per BSE Announcement Dated on 14.10.2022)

EGM Date: 06 Mar 2024

Board Meeting Outcome

EGM Date: 20 Mar 2025

Outcome of Board meeting under regulation 30 of SEBI (Listing obligation and disclosure requirement Regulation), 2015 Notice of the Extra Ordinary General Meeting of the company to be held on 20.03.2025 (As per BSE Announcement Dated on 25/02/2025)0 Clarification Regarding Date Mentioned in covering letter for Notice of Extraordinary General Meetings (EGM) (As Per BSE Announcement Dated on: 01/03/2025) Outcome of the 1st Extra Ordinary General Meeting held on 20.03.2025 (As Per BSE Announcement dated on 20.03.2025) Disclosure under Regulation 30 of SEBI ( LODR) Regulations, 2015 (As Per BSE Announcement Dated on 27.06.2025)